The immune thrombocytopenia market is experiencing steady growth driven by increasing disease awareness and improved diagnosis rates. Advancements in targeted therapies, including thrombopoietin ...

argenx (ARGX) is building a differentiated autoimmune platform, leveraging VYVGART’s commercial success into a self-reinforcing growth engine. ARGX delivered 63% YoY sales growth in Q1 2026, maintains ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026. "The Bionano business is healthy, with first ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Peer comparisons, or benchmarking, can help libraries better understand their performance and can support everyday decision making, such as establishing baselines and identifying opportunities to ...